Renaissancere Holdings Ltd. Takes $6.51 Billion Position in Trupanion, Inc. $TRUP

Renaissancere Holdings Ltd. bought a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 263,000 shares of the financial services provider’s stock, valued at approximately $6,514,510,000. Trupanion makes up 1.5% of Renaissancere Holdings Ltd.’s holdings, making the stock its 5th biggest position. Renaissancere Holdings Ltd. owned 0.60% of Trupanion at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Kelleher Financial Advisors acquired a new position in shares of Trupanion in the 2nd quarter valued at $42,000. Parallel Advisors LLC raised its holdings in Trupanion by 1,831.9% during the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after buying an additional 1,722 shares during the period. Kemnay Advisory Services Inc. acquired a new stake in Trupanion during the 4th quarter worth about $64,000. Advisory Services Network LLC purchased a new stake in Trupanion during the third quarter valued at about $160,000. Finally, Fifth Third Bancorp lifted its stake in Trupanion by 2,911.1% during the first quarter. Fifth Third Bancorp now owns 7,588 shares of the financial services provider’s stock valued at $194,000 after buying an additional 7,336 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on TRUP shares. Stifel Nicolaus set a $28.00 price objective on shares of Trupanion in a research note on Friday, June 26th. Atlantic Securities set a $42.00 target price on Trupanion in a report on Wednesday, July 15th. Weiss Ratings raised Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, August 12th. Finally, Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $41.60.

Insiders Place Their Bets

In other Trupanion news, EVP Steve Weinrauch sold 6,674 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $22.00, for a total value of $146,828.00. Following the sale, the executive vice president owned 78,062 shares of the company’s stock, valued at $1,717,364. This trade represents a 7.88% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Fawwad Qureshi sold 6,177 shares of Trupanion stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the transaction, the chief financial officer directly owned 2,081 shares in the company, valued at approximately $46,156.58. This represents a 74.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 18,785 shares of company stock worth $422,862 over the last quarter. 5.58% of the stock is currently owned by company insiders.

Trupanion Stock Performance

TRUP stock opened at $29.99 on Tuesday. The firm has a 50 day moving average of $25.72 and a two-hundred day moving average of $26.05. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $49.26. The company has a market capitalization of $1.32 billion, a price-to-earnings ratio of 56.59, a P/E/G ratio of 2.20 and a beta of 1.39. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The business had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.22 EPS. As a group, equities analysts anticipate that Trupanion, Inc. will post 0.59 EPS for the current fiscal year.

Trupanion Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.